Chen Melissa M, Terzic Admir, Becker Anton S, Johnson Jason M, Wu Carol C, Wintermark Max, Wald Christoph, Wu Jia
Department of Neuroradiology, MD Anderson Cancer Center, Houston, TX, USA.
Department of Radiology, Dom Zdravlja Odzak, Odzak, Bosnia and Herzegovina.
Eur J Radiol Open. 2022 Sep 29;9:100441. doi: 10.1016/j.ejro.2022.100441. eCollection 2022.
Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology.
放射学是癌症治疗不可或缺的一部分。与分子检测相比,影像学有其优势。影像学作为一种非侵入性工具,可以不受采样误差影响地评估整个肿瘤,并且在肿瘤学实践中通常会在多个时间点进行采集。影像学数据可以进行数字后处理以进行定量评估。人工智能(AI)在临床影像学中的应用日益增加,这促使放射学成为一门具备数据科学能力的学科,而数据科学在现代肿瘤学中发挥着重要作用。除了简化某些临床任务外,AI的强大之处在于它能够揭示以前未被发现甚至难以被人类感官系统察觉的影像学模式。在此,我们对与肿瘤影像学领域相关的新兴AI应用进行叙述性综述,并详细阐述新兴模式和机遇。我们设想,这些技术进步将在未来几年改变放射学,实现成像采集的优化,并发现用于癌症诊断、分期和治疗监测的临床相关生物标志物。它们共同为精准肿瘤学的未来临床转化铺平了道路。